India should prioritise double vaccinating its eligible population against Covid over booster shots given the large number of people still to get the base layer of protection against the infection,......
The World Health Organization is likely to take a decision on including Bharat Biotech's COVID-19 vaccine Covaxin in the emergency use list (EUL) within four to six weeks, Soumya Swaminathan, the......
Johnson & Johnson announced that its single-shot COVID-19 vaccine showed promising signs of protection against the Delta variant rapidly spreading across the United States and other countries, in a......
Global healthcare major Johnson & Johnson on Tuesday said it has sought an approval from the India's drug regulator to conduct a bridging clinical trial of its single-dose COVID-19 vaccine in the......
Global healthcare major Johnson & Johnson is in discussions with the Indian government to begin a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday.......
Experts tracking the treatment of TB are excited about the TB drug, but warn of the unregulated use of drugs in India leading to growing incidence of drug resistance Sirturo, the bedaquiline drug......
Sun Pharmaceutical Industries on Tuesday said it has received US health regulator's approval to market generic version of Doxil injection, used in treating ovarian cancer in the American market.......
The world of big pharma and that of cultural heritage protection do not obviously overlap. But in fact there are logical connections, or so claims Dr Alex Valcke, vice president of one of the......
New drug discovery and contract research have taken a back seat as global drug majors have slowed down their research and development offshoring to India. The domestic players could only manage......
The Canadian health and drug regulator Health Canada has asked Ranbaxy Pharmaceuticals Canada (RPCI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL) to withdraw its generic, 25......